(Q48622012)

13 February 2018

title

Alterations in the cortical serotonergic system in schizophrenia: a postmortem study (English)

1 reference

13 February 2018

Alterations in the cortical serotonergic system in schizophrenia: A postmortem study (English)

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(97)00321-1

25 November 2024

0 references

E. V. Gurevich

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9376449

25 November 2024

J. N. Joyce

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9376449

25 November 2024

language of work or name

English

0 references

publication date

1 October 1997

1 reference

13 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0006322397003211?httpAccept=text/plain

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(97)00321-1

https://api.elsevier.com/content/article/PII:S0006322397003211?httpAccept=text/xml

25 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(97)00321-1

25 November 2024

published in

Biological Psychiatry

1 reference

13 February 2018

volume

42

1 reference

13 February 2018

issue

7

1 reference

13 February 2018

page(s)

529-545

1 reference

13 February 2018

Age stability of human brain 5-HT terminals studied with [3H]paroxetine binding

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Differential effect of subchronic treatment with various neuroleptic agents on serotonin2 receptors in rat cerebral cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Prospective clinicopathologic studies of schizophrenia: accrual and assessment of patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Altered frontostriatal relationship in unmedicated schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

High-affinity binding of [125I]RTI-55 to dopamine and serotonin transporters in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

[3H]paroxetine binding is altered in the hippocampus but not the frontal cortex or caudate nucleus from subjects with schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Serotonin2 receptors and the serotonin transporter in the schizophrenic brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Effects of the 5-HT2 receptor antagonist, ritanserin, on biogenic amines in the rat nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Hypofrontality revisited: a high resolution single photon emission computed tomography study in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Selected quantitative EEG (QEEG) and event-related potential (ERP) variables as discriminators for positive and negative schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Disrupted pattern of D2 dopamine receptors in the temporal lobe in schizophrenia. A postmortem study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Comparison of [3H]paroxetine and [3H]cyanoimipramine for quantitative measurement of serotonin transporter sites in human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Differential changes in serotonin 5-HT1A and 5-HT2 receptor binding in patients with chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Limbic circuits and monoamine receptors: Dissecting the effects of antipsy chotics from disease processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Differential regulation of rat 5-HT2A and 5-HT2C receptors after chronic treatment with clozapine, chlorpromazine and three putative atypical antipsychotic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Serotonergic serotonin 2 receptor modulation on DOPAC and 5-HIAA levels in rat striatum and nucleus accumbens: microdialysis studies of freely moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Frontal brain volume and context effects in short-term recall in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Effects of subchronic treatments with SM-9018, a novel 5-HT2 and D2 antagonist, on dopamine and 5-HT receptors in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Neuropsychological and olfactory dysfunction in schizophrenia: relationship of frontal syndromes to syndromes of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Schizophrenia: a disease of heteromodal association cortex?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Myelo- and cytoarchitecture of the granular frontal cortex and surrounding regions in the strepsirhine primate Galago and the anthropoid primate Macaca

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Cytoarchitectonic Definition of Prefrontal Areas in the Normal Human Cortex: I. Remapping of Areas 9 and 46 using Quantitative Criteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Schizophrenia, the heteromodal association neocortex and development: potential for a neurogenetic approach.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Relationship of prefrontal and temporal lobe MRI measures to neuropsychological performance in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

The effect of chronic treatment with a novel aryl-piperazine antipsychotic on monoamine receptors in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Autoradiography with [3H]8-OH-DPAT reveals increases in 5-HT1A receptors in ventral prefrontal cortex in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Cytoarchitecture and intrafrontal connections of the frontal cortex of the brain of the hamadryas baboon (Papio hamadryas)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Negative symptoms and hypofrontality in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

Serotonin (5-HT2) receptor mediated enhancement of cortical unit activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900321-1

inferred from DOI database lookup

7 January 2021

based on heuristic

The current status of the dopamine hypothesis of schizophrenia

series ordinal

13

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(97)00321-1

In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone

25 November 2024

series ordinal

28

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(97)00321-1

25 November 2024

Identifiers

1 reference

13 February 2018

1 reference

13 February 2018